Nurse Practitioner, Family · Brooklyn, NY
NPI
1467107136
Since 2022
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
902 Quentin Rd
Brooklyn, NY, 11223
Phone (917) 736-9740
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
1,284 services
Medicare patients, 2024
477
Average age 78
Drug cost, 2024
$9.2M
1,424 prescriptions
Company payments, 2025
$2,700
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anita Gokhfeld was code 36415 (venipuncture blood collection), 1,050 times for 475 patients. In total Anita Gokhfeld billed 1,284 services in 5 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 1,050 | 475 | $8.65 | $9,083 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 102 | 76 | $12.37 | $1,262 |
| 99213 Office E&M - Established | Office | 89 | 73 | $63.56 | $5,657 |
| 99214 Office E&M - Established | Office | 42 | 33 | $74.58 | $3,132 |
By year: 2022 $5,331 for 124 services; 2023 $8,766 for 208 services; 2024 $19K for 1,284 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,050 | 475 | $8.65 | $9,083 |
Medicare prescription drug claims, 2024
In 2024, the drug Anita Gokhfeld prescribed most often to Medicare patients was Hydroxyurea, with 130 prescriptions and refills. In total Anita Gokhfeld wrote 1,424 Medicare prescriptions that cost $9.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 130 | 193 | 32 | $2,461 |
| Eliquis Apixaban | 70 | 81 | 19 | $48K |
| Lenalidomide Generic | 68 | 68 | Under 11 | $939K |
| Jakafi Ruxolitinib Phosphate | 67 | 67 | Under 11 | $927K |
| Acyclovir Generic | 66 | 80 | 15 | $623 |
| Xarelto Rivaroxaban | 55 | 75 | 13 | $40K |
| Pomalyst Pomalidomide | 55 | 56 | Under 11 | $1.1M |
| Aranesp Darbepoetin Alfa In Polysorbat | 52 | 55 | 16 | $137K |
| Letrozole Generic | 46 | 67 | 11 | $506 |
| Imbruvica Ibrutinib | 46 | 46 | Under 11 | $739K |
| Anagrelide Hcl Generic | 45 | 51 | Under 11 | $9,542 |
| Brukinsa Zanubrutinib | 43 | 43 | Under 11 | $605K |
| Prednisone Generic | 39 | 41 | Under 11 | $196 |
| Imatinib Mesylate Generic | 38 | 38 | Under 11 | $83K |
| Revlimid Lenalidomide | 38 | 38 | 13 | $657K |
Brand drugs: 747 claims; generic drugs: 677 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anita Gokhfeld $2,700 ($2,700 in general payments such as food, travel and fees) from 29 companies. The largest payer was Janssen Biotech, Inc. with $431.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 16 | $431 |
| Novartis Pharmaceuticals Corporation NVS | 20 | $291 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $226 |
| E.R. Squibb & Sons, L.L.C. BMY | 8 | $209 |
| GlaxoSmithKline, LLC. GSK | 7 | $167 |
| Sobi, Inc SOBI.ST | 6 | $161 |
| Gilead Sciences, Inc. GILD | 4 | $157 |
| Incyte Corporation INCY | 2 | $119 |
| PharmaEssentia USA Corporation 6446.TW | 4 | $78.61 |
| Agios Pharmaceuticals, Inc. AGIO | 3 | $73.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.